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Abstract
Perinatal depression and perinatal anxiety can affect up to 20% of women during pregnancy and postpartum. Babies exposed to these pathologies suffer 
consequences in their development at a cognitive, motor, emotional and social level. Some of these can be observed since birth. In addition, adverse effects 
have been described in the behavior of the newborn exposed to psychopharmacotherapy during pregnancy. The aims of the study were to observe the neonatal 
behavior of babies exposed to perinatal depression or anxiety and to compare it between both diagnostic groups of mothers. The cohort included 86 new-
borns, from 2 to 67 days of chronological age (29 ± 13.4, 48% females), exposed to maternal depression (n = 27) or anxiety (n = 59). The Neonatal Behavior 
Assessment Scale, 4th edition, (Brazelton and Nugent, 2011) was administered at a maternal mental health unit to register the neonatal behavior. Chi-square 
and Student t-test analyses were calculated to compare item scores and percentages of suboptimal responses between both groups; Pearson correlations 
were calculated to analyze the relation of obstetric and psychiatric variables of mothers and the behavior of newborns. Significant differences between groups 
were found only regarding the change in skin color, with higher percentages of suboptimal responses in the group exposed to anxiety than to depression (24% 
versus 4%, Chi2 = 3.89; p < .05). Correlation analyses show that, although the birth weight is positively related to the interactive social orientation (tracing face 
and voice: r = .28, p = .02), the last was affected negatively by the dose of antidepressants during the third trimester of pregnancy (tracing face and voice: r = 
-.31, p = 0.03), indicating that higher doses of antidepressant was related with lower interactive social orientation. Our findings emphasize the need to detect 
depression and anxiety in women during the perinatal period in order to intervene at a multidisciplinary level in both, mother and baby, and the relation.
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Resumen
Conducta neonatal en bebés expuestos a trastornos de depresión y de ansiedad maternos durante el período perinatal. La depresión y la ansiedad perinata-
les afectan hasta el 20% de las mujeres durante embarazo y postparto. Los bebés expuestos a ellas sufren consecuencias en su desarrollo a nivel cognitivo, 
motor y socioemocional, y pueden observarse desde el nacimiento. Además, se han descrito efectos adversos en la conducta del neonato expuesto a psico-
fármacos durante la gestación. Los objetivos de este estudio fueron observar la conducta neonatal de bebés expuestos a depresión y ansiedad perinatal y 
compararla entre ambos grupos de diagnóstico materno. La cohorte incluyó 86 neonatos, entre 2 y 67 días de edad cronológica (29 ± 13.4, 48% mujeres), 
expuestos a depresión (n = 27) o ansiedad (n = 59) materna. La Escala de Evaluación de la Conducta Neonatal, 4ª edición, (Brazelton y Nugent, 2011) fue 
administrada en una unidad de salud mental perinatal para registrar la conducta neonatal. Se realizaron análisis de Chi-cuadrado y t de Student para comparar 
las puntuaciones en los ítems y los porcentajes de respuestas subóptimas entre ambos grupos; se calcularon índices de correlación de Pearson para analizar 
la relación entre variables obstétricas y psiquiátricas de las madres y la conducta de los bebés. Únicamente se encontraron diferencias significativas entre 
los grupos diagnósticos respecto al cambio del color de la piel, con porcentajes mayores de respuesta subóptima en el grupo expuesto a ansiedad que a 
depresión (24% versus 4%, Chi2 = 3.89; p < .05). Los análisis de correlación muestran que, aunque el mayor peso al nacer se relaciona positivamente con la 
respuesta social-interactiva (orientación a cara y voz: r = .28, p = .02), ésta se ve afectada negativamente por el uso de antidepresivos durante el tercer trimes-
tre de gestación (orientación a cara y voz: r = -.31, p = .03), indicando que a mayores dosis, peor orientación social-interactiva. Nuestros hallazgos enfatizan 
la necesidad de detectar la depresión y la ansiedad en las mujeres durante el período perinatal para intervenir a nivel multidisciplinar sobre ambos, madre y 
bebé, y sobre la relación.
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NBAS IN BABIES EXPOSED TO DEPRESSION AND ANXIETY
Introduction
During pregnancy, childbirth and postpartum, women are at high 
risk of developing a mental disorder. This period, called “perinatal 
period” begins in gestation and ends in the first year of the baby’s life. 
It is common that levels of anxiety and depression increase during 
this period, like other mental health problems. It is crucial to focus on 
these, due to the consequences for the mother and her child. 
Pregnancy impacts woman on a biological, psychological and 
social level. At a biological level, involves hormones (such as estrogens, 
progesterone, glucocorticoids, prolactin and oxytocin) that can mod-
ify structures in the mother’s brain, in order to adapt her to the future 
needs of motherhood (Pasqualini & Chetrite, 2016). These changes 
will later affect the mother’s responses to the newborn’s attachment 
behaviors. Once the baby is born, the mother again experiences hor-
monal changes, such as the suppression of estradiol and progesterone 
levels, the suppression of the hypothalamic-pituitary-adrenal axis or 
the attenuation of serotonergic activity, which leads the mothers to a 
greater vulnerability to emotional disturbances (Newman et al., 2016). 
Other psychological and social factors could also trigger emotional 
alterations, due to changes in family and personal relationships, in her 
body, in diet, in daily activities, but also due to the experience of com-
plicated previous gestations grieving processes and even traumatic 
childbirths (Gómez, 2007; Lera Miguel & Andrés Perpiñá, 2019). 
The World Health Organization states that 15% of women world-
wide suffers from a mental health problem during the perinatal 
period (WHO, 2020). Only about 5.5% of them receives some kind of 
treatment (Andersson et al., 2003).
Perinatal Depression
Depression during pregnancy or prenatal depression, has an 
incidence range between 6% and 38% (Field, 2011). García Esteve 
and Valdés (2016) stated that, among alterations in perinatal men-
tal health, the major depressive episode occurs in 8% of pregnant 
women, while the diagnosis of dysthymia occurs in 1%. Depression in 
pregnancy is associated with an increased risk of obstetric and neona-
tal complications in the mother and the baby and alterations in short- 
and long-term development.
Postpartum depression is characterized by the frequency of occur-
rence, as well as the intensity of the depressed mood regarding other 
periods of life. Mendoza and Saldivia (2015) stated that the period 
of higher risk or greatest vulnerability for postpartum depression are 
the first three months after delivery. Prevalence rates of postpartum 
depression around the world are in a range from 10 to 20% of moth-
ers, increasing up to 26-38% if mothers were adolescent of low socio-
economic levels (Mendoza & Saldivia, 2015).
Perinatal anxiety 
Recently, maternal stress and clinical anxiety have been recog-
nized as important as depressive states. These disorders describe the 
mother’s concerns about her physical appearance, her financial situa-
tion, or intense fears about childbirth and some type of child disabil-
ity. The prevalence of anxiety disorders during pregnancy is around 
10% in developed countries and around 25% in developing countries 
(Shahhosseini, et al., 2015). Approximately 8% of women in this 
period are diagnosed with generalized anxiety disorder (GAD) and 
3% with panic disorder. A meta-analysis by Goodman, Watson and 
Stubbs (2016) concluded that 9% of women experienced one or more 
postpartum anxiety disorders. In fact, some authors point out that 
perinatal anxiety is more prevalent than depression: 54% of women 
experienced increased anxiety at some point in pregnancy, while 37% 
met criteria for depression (Lee et al., 2007).
Effects of perinatal depression and anxiety over the fetus 
and newborn 
As mentioned, mental health disorders have an impact in women, 
but also in the fetal and newborn development at a physiological, 
cognitive, motor and emotional level (Field, 2011). Both prenatal 
depression and anxiety were associated with an increased risk for 
prematurity and low birth weight. Higher levels of hormones associ-
ated with stress, such as cortisol and norepinephrine, and lower lev-
els of dopamine and serotonin were found among the newborns of 
women with these diagnoses (Field et al., 2011). In addition, a poor 
reactivity response to the Brazelton Neonatal Behavior Assessment 
Scale (NBAS) was observed in infants exposed to prenatal maternal 
depression, manifested in a deficit of social interactive orientation 
to the human face and voice (Field, 1998, 2011). Instead, high levels 
of prenatal anxiety were related to a poor performance in the NBAS 
domains of motor system and stability of the autonomic nervous 
system, added to the same low orientation to social interaction 
(Vázquez, et al., 2005). Both disorders have been associated with 
difficult tem-perament of the baby and with sleep disturbances 
(Britton, 2011; Field, 2011; McGrath et al., 2008).
Pharmacological treatment of prenatal depression and 
anxiety 
Some studies have shown that the use of psychopharmacs during 
pregnancy was related with congenital malformations (40% have 
an unknown origin and 2-3% of these are due to drugs), obstetric 
compli-cations, spontanous abortion or miscarriage, gestational 
diabetes, poor neonatal adaptation syndrome (PNAS), and child 
long-term develop-mental adverse effects. The decision for drug 
therapy during preg-nancy should be weighed in a conscious and 
informed way according to the benefits that long-term medication 
means for both, mother and baby (Bellantuono, et al., 2012; García-
Esteve & Valdés, 2016). 
It has been described how, in adults, the abruptly 
discontinuation of the treatment with antidepressants, 
antipsychotics, and benzodiaz-epines can cause withdrawal 
symptoms. As known, psychopharmacs cross through the placenta 
to the baby; therefore, an abrupt cessation at birth can lead the 
baby to the same withdrawal symptoms, some of them observed 
until 8 hours after the birth. These symptoms are characterized by 
feeding difficulties, increased irritability and tremors (Kievit et al., 
2013). The use of Selective Serotonin Reuptake Inhibitors (SSRIs) 
during pregnancy has increased in recent years; about 2-3% of 
pregnant women use them. Kievit et al. (2013) concluded in a 
revision that 30% of babies exposed to SSRIs showed symptoms of 
PNAS.
In summary, not treating perinatal mental disorders can lead 
to several medical complications in the baby which are a high risk 
for prematurity and for low birth weight, due to the high transfer of 
corti-sol levels from mother to fetus, but also to psychological 
disturbances, such as irritability and agitation, poor alert 
responses and facial expression. Finally, the mother’s symptoms 
and the baby tempera-ment could affect the bond between them, 
which also would affect his/her behavior in the future.
The main objective of this study was to describe the 
neonatal behavior, measured with the NBAS, 4th edition, (Brazelton 
& Nugent, 2011), of babies exposed to perinatal depression and 
anxiety of moth-ers attended in a maternal mental health unit. The 
secondary objec-
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tives were to compare the neonatal behavior of the children of moth-
ers diagnosed with depression and those who were exposed to anxiety. 
Taking into account these objectives, it is expected to find that 1) 
The babies of mothers with a diagnosis of depression will show similar 
response of interactive social orientation than the babies of the anxiety 
group; 2) Newborns of mothers with a diagnosis of anxiety will show 
poorer range of the emotional state, indicated by higher irritability 
and instability of autonomic nervous system, and 3) Babies exposed 
prenatally to antidepressants will show higher emotional instability 
and lower alertness than babies not exposed.
Method
Participants
A sample of 191 neonates have been evaluated with the NBAS, 
4th edition (Brazelton & Nugent, 2011) in our clinical setting, in the 
period 2014-2019. For this study, newborns whose mothers had been 
diagnosed during pregnancy with any of the following disorders were 
selected and were grouped as follows: 1) Depression: single episode 
or recurrent major depression, dysthymia, postpartum depression, 
psychotic depression or 2) Anxiety: panic disorder with or without 
agoraphobia, unspecified anxiety disorder, generalized anxiety disor-
der, obsessive-compulsive disorder. From the whole sample, 96 babies 
were exposed to maternal depression or anxiety disorders; those 
babies born preterm (<37 weeks) were removed from the analyses. 
The final sample included 86 newborns.
Instruments
The Neonatal Behavior Assessment Scale, 4th edition (NBAS; Bra-
zelton & Nugent, 2011) is used to observe the behavioral organization 
and the skills to respond to external stress and extra-uterine environ-
ment, but mainly to return feedback to parents about how their child 
is and how can they adapt better to satisfy the baby needs. It can be 
administered to healthy or to at-risk newborns up to 60 days of life. 
The NBAS is based on the observation of the baby’s behavior when 
presenting stimuli to him or her. It consists of 35 behavioral items 
grouped into 6 domains or factors, in addition to 18 reflexes. For 
this study, all the behavioral items were taken into account (without 
reflexes), most of which were scored on a scale of 0 to 9 points, and 
some of which in scales 0 to 6 or 0 to 5, where 0 describes the absence 
of response or the worst response and 9/6/5 represents the optimal 
response. The six domains of the behavioral items are described below:
 – Habituation (four items): how the baby is able to inhibit itself
from repetitive and disturbing stimuli while sleeping (light, rattle, 
bell and tactile stimulation).
 – Social interactive orientation (seven items): the ability to fixate and 
follow visual and auditory stimuli, human and non-human, which 
will be the basis of communicative competence.
 – Motor system (five items): volume of motor activity, quality of
movements and muscle tone.
 – Range of the state (four items): emotional stability-instability in
response to external stimuli, and the intensity, volume, speed of
reaction and duration.
 – State regulation (four items): newborn’s resources to console him-
self and regain stability in coping stimuli.
 – Autonomic nervous system lability (three items): frequency of
tremors, changes in skin color, and startles.
Sociodemographic and clinical variables were registered from the 
medical history which included: age of the mother at delivery, age of 
the baby, duration of gestation in weeks, type of delivery, presence and 
type of obstetric risk, principal psychiatric diagnosis before pregnancy 
and current perinatal psychiatric diagnosis (according to the criteria 
of the Diagnostic and Statistical Manual for Psychiatric Disorders, 5th 
edition (DSM-5, APA, 2013) and, in case of antidepressant treatment, 
dosage (times of minimal therapeutic dose).
The clinical guidelines of our maternal mental health unit include 
the assessment of the babies in different time points along the fi rst 
year of life. Two certified evaluators (SAP, SLM) administered the 
NBAS, according to the standardized conditions of the scale. Each 
caregiver receives necessary feedback on the baby’s performance by 
making some suggestions and recommendations. Data of the NBAS 
were registered in direct scores and also dichotomized into optimal 
or suboptimal response after being anonymized. For items scored on 
a scale up to 9, the scores were dichotomized as optimal if they were 
between 7 and 9, for items with scores up to 6, the optimal ones were 
between 5 and 6, and for items scored up to 5, the optimal ones were 
between 4 and 5. 
Ethical Review Board of our institution approved this study.
Statistical analysis 
Means (M), standard deviations (SD) and frequencies (n) have 
been extracted for the sociodemographic and clinical variables 
of mothers and babies. In addition, contingency tables and chi-
square analyses have been extracted to compare the percentages 
in each domain of suboptimal responses. Student’s t-tests (t) have 
been calculated to compare the responses of the babies exposed to 
prenatal depression or to anxiety. Pearson correlation indexes (r) 
were also calculated to analyze possible relationships between the 
antidepressant dose, birth weight, length of gestation, and 
chronological and post-menstrual age of the baby. The analyses 
were done with the statistical program SPSS 25.0.
Results
Sociodemographic and clinical data of mothers and 
babies 
Table 1 reflects sociodemographic, clinical and obstetric data for 
each subgroup of newborns. Mothers of the babies in this study, had 
an age between 22 and 51 years of age (M = 36.33, SD = 4.39), with a 
mean of 36 years old. The gestation period in weeks of our sample was 
between 37 and 42 weeks (M = 39.09, SD = 1.27 weeks). Forty-nine 
percent of newborns were girls and 51%, boys. Regarding the type of 
delivery, cesarean was performed in 39% of deliveries and another 39% 
were eutocic, 13% were induced and 8%, instrumentalized. Fifty-eight 
percent of the sample had an obstetric problem, being gestational dia-
betes (8%) and preeclampsia (7%) the most registered. Babies were 
assessed with the NBAS in a range between 2 and 67 days of chrono-
logical age (M = 29.03, SD = 13.4) and between 39 and 47 weeks (M 
= 43.32, SD = 2.10) of postmenstrual age (time between conception 
and moment of the evaluation). Eighty-four percent of the depressed 
or anxious mothers of our sample had been previously diagnosed 
with a mental disorder before the perinatal period, being panic disor-
ders with/without agoraphobia (16%), recurrent depressive disorder 
(12%), obsessive-compulsive disorder (11%) and unspecified anxi-
Procedure
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ety disorders (7%) the most common. Only a 1% of the mothers had 
been diagnosed as postpartum depression in previous pregnancies. 
The most diagnosed disorders during the index perinatal period were 
unspecified anxiety disorder (33%) followed by panic disorder with/
without agoraphobia (17%), recurrent depressive disorder (13%) and 
obsessive-compulsive disorder (13%). Only the 4% of the women in 
the current sample were diagnosed as postpartum depression. Thus, 
diagnostic subgroups were formed by 31% of newborns from mothers 
with depressive disorder (n = 27) and 69% of newborns from mothers 
with anxiety disorders (n = 59).
Eighty-four percent of the sample received drug treatment dur-
ing second and third trimester of pregnancy. Considering the women 
taking antidepressants as the principal psychopharmacological class 
(74% of total sample), 17% received fluoxetine (n = 15), 16% escitalo-
pram (n = 14) and 13% sertraline (n = 11). Almost 26% of our sam-
ple received only the benzodiacepine lorazepam during this period. 
Two women received the atypical antipsychotic aripiprazole and two 
received the anticonvulsivant lamotrigine as a principal treatment.
Neonatal response of newborns to NBAS domains
More than two thirds of newborns showed optimal habituation to 
external stimuli presented during the sleep (72% to light, 87% to rattle, 
70% to bell, 74% to tactile stimulus). However, little more than a half of 
newborns oriented optimally to the animated and unanimated visual, 
visual-auditory and auditory stimuli of the social interactive domain 
(61% to face, 52% to face-voice, 46% to ball, 51% to rattle; 78% to voice, 
59% to rattle), with low quality of alertness (55%). Most of the babies 
manifested an optimal muscular tone (82%) and motor activity (89%) 
and maturity (71%), but, contrary, the response to seat incorporation 
was suboptimal (only 25% was optimal). Most of the newborns had 
a quick response to irritability (only 24%, optimal), although not to 
many stimuli (78%, optimal response) and not for long (81%, optimal 
response in excitement); high change between psychophysiological 
states was observed in almost 40% of the newborns. Regarding the reg-
ulation skills, 68% had an optimal response to the cuddle but almost all 
presented suboptimal response to consolation skills (only 18%, opti-
mal) and did not manifest own skills to search self-comfort (10%). A 
31-38% reacted with frequent startles and tremors.
Differences between babies exposed to depression and
anxiety 
There are no differences between the means of two groups for 
mother age at delivery, duration of pregnancy, baby chronological and 
postmenstrual ages and birth weight. Percentages of type of delivery, 
presence of obstetric risk, sex of babies or exposition to psychophar-
macological treatment were similarly distributed between groups (p > 
.05). Table 2 shows the scores to NBAS items and the percentages of 
suboptimal response in each diagnostic group.
Taking into account the scores in each item, the neonatal behav-
ior of babies exposed to perinatal depression did not significantly dif-
fer from babies exposed to perinatal anxiety disorders in any direct 
score on the NBAS scale; a trend to statistical significance is observed 
in motor maturity (t = -1.79; p = .077), indicating a worse response 
among the babies exposed to maternal depression. Related to percent-
ages of suboptimal responses, greater percentage of babies exposed to 
perinatal anxiety (24%) showed suboptimal stability of the autonomic 
nervous system (ANS), specifically in change on skin color, in front of 
the 4% of suboptimal responses in babies exposed to depression (chi-
square = 3.89; p = .048). No other significant differences were found 
between diagnostic groups.
Correlations between obstetric variables and baby’s 
responses in NBAS
In order to control other variables which could affect the behavior 
of the baby, it was found that the length of gestation is positively cor-
related with the quality of the alert (r = .24, p = .038). The mother’s age 
did not correlate with any score on the NBAS scale. The birth weight 
correlated positively with social interactive orientation (tracing face: 
r = .31, p = .012; tracing face and voice: r = .28, p = .022; alertness: r 
= .26, p = .027) and negatively with range of state (maximum volume 
of excitement: r = -.23, p= .043), indicating that more mature babies 
showed better orientation to social interactions, but also, more emo-
tional instability.
Table 1. Demographic, obstetric and clinical data of mothers and babies 








Mother age at delivery 36.2 ± 5.8 36.4 ± 3.4 -.20
Gestation period (weeks) 38.8 ± 1.02 39.2 ± 1.4 -1.3
Baby chronological age (days) 30 ± 11.7 29 ± 14.1 .42
Baby postmenstrual age (weeks) 43.1 ±  2 43.4 ± 2.2 -.74






Sex (female) 48% 47.5% 2.257
Obstetric risk (yes) 70% 41% 2.624











Panic disorder /Agoraphobia 16.3%







With psychotic symptoms 1.2%
Post-partum 3.5%
Dysthymia 2.3%
Panic disorder /Agoraphobia 17.4%





Use of psychopharmacs during 
2nd-3rd trimester
77.8% 86.4% 1.020
Significant p-values are stated at .05; *p<.05; **p<.01.
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Finally, it was found that the higher the antidepressant dose 
received, the worse the response to the social interactive orientation 
(tracing to face and voice: r = -.31, p = .032; alertness: r = -.33, p = 
.021). It is also related to a lower range of state (maximum volume of 
excitement: r = -.33, p = .011) and to a worse habituation during sleep 
to sound stimuli (bell: r = -.55, p = .033).
In summary, higher doses of antidepressant during 3rd trimester 
was related to worse social interactive orientation and to a lower sta-
bility of the psychophysiological states.
Discussion
The main aim of this study was to analyze the neonatal behavior of 
newborns exposed to prenatal depression and anxiety from a cohort 
of mothers with mental disorder treated in a specialized department 
of perinatal mental health.
According to our diagnostic groups, perinatal anxiety disorders 
(69%) were more prevalent than depressive disorders (31%) in our 
sample of assessed newborns, which agreed with the observations of 
Lee et al. (2007). Nevertheless, the prevalence of defined anxiety and 
depression diagnoses in the wide original sample of 191 newborns 
assessed in the maternal mental health unit was different, with higher 
rates for panic disorders with/without agoraphobia (15%) and depres-
sive episodes (11%) and lower rates for generalized anxiety disorder 
(less than 3%) in relation to previous studies (Garcia-Esteve & Valdés, 
2016; Goodman et al., 2016), pointing out that women attended in 
our specialized setting suffered from more severe disorders. Although 
preterm newborns were removed from the analyses, the risk for pre-
maturity is also increased in our specific sample of 96 mothers with 
prenatal depression and anxiety: 10% in front of the 6% rated for gen-
eral population in our country (Idescat, 2019), reflecting the negative 
effect of maternal stress over pregnancy.
Babies of this current sample, exposed to depressive or anxious 
symptoms during pregnancy or first weeks of postpartum, were char-
acterized by diminished social interactive behavior, reduced scope 
of arms movements and head firmness, fast irritation to stimulation, 
rather high variability of the emotional states and ineffective response 
to consolation. Previous studies and reviews have reflected poorer 















Light 7.3  ± 1.83 6.9 ± 2.4 .36 37.5% 25.9% .46
Rattle 8.8 ± .50 7.7 ± 1.6 1.32 0% 16% .92
Bell 7.7 ± 1.53 7.2 ± 2.6 .33 33.3% 30% .14
Pin-Prick 8.3 ± .58 7.1 ± 2.3 .93 0% 31.3% 1.3
6.4 ± 2.7 5.7 ± 2.7 1.0 45% 58.7% 1.06




    Animated Visual (face) 
Animated Visual-auditive (face-voice)
6.9 ± 2.1 6.4 ±2.4 .91 30.4% 42.6% .96
Inanimated Auditive (rattle)
6.9 ± 1.7 6.7 ± 1.8 .63 41.7% 51% .57
Animated Auditive (Voice)
Alertness
5.9 ± 1.9 6.5 ± 1.9 -1.1 48% 37% .818
6.9 ± 1.9 7.4 ± 1.5 -1.2 22.7% 21.7% .008
6.1 ± 1.8  6.5 ± 1.9 -8.6 53.8% 40.4% 1.3
Motor:
Maturity 6.8 ± .83 7.2 ± 1.0 -1.8 33.3% 26.8% .38
Pull to sit 5.1 ± 2.1 5.1 ± 2.2 -.11 78.3% 73.6% .18
Defense 6.3 ± 1.6 6.9 ± 1.4 -1.7 42.9% 29.2% 1.2
Tonus 5.5 ± .98 5.4 ± .88 .45 14.8% 19.3% .25
Activity 4.4 ± .97 4.6 ± .65 -1.4 14.8% 8.9%
Range of State:
Rapidity of Build-up 3.4 ± 1.9 1.8 ± 1.6 1.5* 72% 77.2% .25
Irritability 5.1 ± 1.5 4.9 ± 1.7 .34 13% 25.5% 1.5
Peak of Excitement 3.7 ± .9 3.9 ± 1.1 -.85 22.2% 16.9% .34
Lability of State 3.5 ± 1.6 2.9 ± 1.7 1.3 37% 48.3% .94
State Regulation:
Cudliness 46.8 ± 1.8 6.8 ± 1.7 .27 29.6% 32.7% .08
Consolability 4.2 ± 1.9 4.3 ± 1.9 -.22 94.4% 76.9% 2.6
Self quieting 2.6 ± 1.8 2.7 ± .20 -.10 100% 85% 3.0
Hand to mouth 3.0 ± 2.2 3.1 ± 2.4 -.066 96.3% 91.1% .74
Lability of ANS:
Tremolousness 7.1 ± 2.6 6.8 ± 2.7 .483 37% 38% .02
Lability of Skin Color 4.4 ± .51 4.3 ± .97 1,1** 3.8% 20.7% 3.9
Startles 7.4 ± 2.5 6.9 ± 2.4 .72 25.9% 32.8% .41
ANS: Autonomous Nervious System. Significant p-values are stated at .05; *p<.05; **p<.01.
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social interactive orientation, suboptimal motor responses and insta-
bility of the ANS in newborns exposed to maternal stress (Field, 1998; 
Field et al., 2011; Vázquez et al., 2005) and other, more recently pub-
lished, have found suboptimal performance in babies from mothers 
with prenatal depression also in the range and the regulation of the 
state, as it has been observed in our sample (Osborne et al., 2018).
The comparation between diagnostics showed significant dif-
ferences between babies exposed to perinatal maternal depression 
or to anxiety in only one item (change of skin color); consequently, 
and contrary to our hypothesis, it is adequate to state that there were 
no differences in the affectation of these two groups of psychopatho-
logical symptoms over the neonatal behavior in our sample of babies 
from treated mothers. These findings were not agreeing with previous 
studies that observed worse social interactive orientation in babies 
exposed to depression compared to anxiety (Field, 2011) but converge 
with studies that found lower performance on ANS among those 
exposed to anxiety (Vázquez et al., 2005). This could be due to the 
fact that our mothers were receiving a multidisciplinary therapy pro-
gram during pregnancy and postpartum that could have produced a 
reduction the experience of stress in both group of mothers, not based 
only in psychological and psychopharmacological treatment, but also 
in the intervention on the bond and parenting skills. The reduction 
of the obstetric risks associated to prenatal depression due to antide-
pressant treatment has received support in the literature (Jarde et al., 
2016; Venkatesh et al., 2017) but there is no published research about 
multidisciplinary treatments.
Finally, the current study analyzed the effect of antidepressant 
dosage and found a relation of higher doses with a worse response in 
the social interactive items (face and voice), a longer response time, 
more volume of irritability-crying states and a worse habituation dur-
ing sleep to sound stimulus. Kievit et al. (2013) observed withdrawal 
signs in the baby exposed to prenatal antidepressants, such as high 
irritability and difficulties in sleeping. Our findings could be aligned 
with the fact that the exposure to high doses of antidepressants was 
not the unique factor explaining these suboptimal responses to NBAS, 
but it produced additive effects over the injury due to the exposure 
to chronic and severe maternal states of stress and depression, given 
that higher doses of SSRI were administered to higher severity of 
symptoms (Andrade, 2017; Hermansen & Melinder, 2015). Further 
research has to been still considered to isolate both effects.
One of the limitations of the study is based on the fact that the 
syndromic groups have been cataloged according to DSM-5 clinical 
diagnoses; however, clinical questionnaires about anxiety and depres-
sion were not administered to all women of the sample and have not 
been considered in the current analyses. A second limitation was that 
the lack of a control group of mothers and babies of general population 
did not allow the analyses of significant deficits for the clinical sample. 
Having a larger subgroup of treated mothers without pharmacological 
treatment would be useful to know more robustly the additive effects 
of psychopharmacological treatment over the symptom’s severity in 
the affectation of the neonatal behavior as well as to compare different 
kinds of treatment. The same would be useful regarding to control the 
additive effect of obstetric risks, such as gestational diabetes or pre-ec-
lampsia in these mothers with depression and anxiety disorders. In 
addition, other variables such as the maternal substance use (nicotine, 
caffeine, alcohol, cannabis and others illicit drugs) have not been reg-
istered, neither the existence of previous children, which in some way 
could also affect the experience of anxiety during pregnancy.
As a final conclusion, we want to reinforce the importance of con-
tinuing to create specialized units in perinatal mental health to support 
mother-infant dyads and ensure their mental health and development. 
To continue the training and the research to observe the neonatal 
behavior, crucial in prevention and early intervention, contributes to 
strengthening the bond mother-child and the stimulation of the com-
munication between the family and their baby. Longitudinal and pro-
spective studies about the response to multidisciplinary treatments for 
mental disorders and maternal skills would be necessary to understand 
the child needs and to adapt to the temperamental traits.
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